This study explored the characteristics of the Borderline Personality Disorder classification, specified in DSM-III. MMPI profiles of 29 male veteran inpatients with a diagnosis of Borderline Personality Disorder were compared with the profiles of 26 similar inpatients with diagnoses of other personality disorders. The borderline group had higher elevations (p less than .05) on six of the 13 standard MMPI scales. Analyses showed the borderline profiles to be of a significantly higher elevation but no different in either profile shape or dispersion. A discriminant analysis accounted for 43.7% of the variance and correctly classified 78.2% of the patients. Results are discussed in terms of possible explanations for the high F scores of the borderline group. Implications regarding characteristics of the Borderline Personality Disorder are discussed.
The EEG's of hospitalized males with the sole diagnosis of borderline personality disorder (n = 37) were compared to those of a group with only dysthymic disorder (n = 31). Borderline patients were found to have significantly more marginal, definite, and combined (marginal and definite) abnormalities on the EEG. The most prevalent abnormality in the borderline was slow-wave activity. The mixture of wave frequencies occurring in the electroencephalogram, known as fusing, occurred significantly more often in the borderline group compared to the dysthymic group. Severity of illness of the borderline group and the depressed group was not significantly correlated with EEG abnormality. Neurophysiologic implications for the pathogenesis of the borderline personality disorder are discussed in light of these findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.